Yoshiyuki Ogawa 研究室

主宰者：Yoshiyuki Ogawa

群馬大学・Gunma University Hospital

AI 要約（直近 5 年の研究成果）

要約はまだ生成されていません。

※ AI（Claude）が、公開されている論文要旨から研究の問い・手法・主要な発見を事実情報として抽出・再構成して自動生成しています。誤りを含む可能性があるため、正確性は研究室公式情報でご確認ください。

外部リンク

研究成果（51 件）

[2026] Real‐World Use of Emicizumab in Patients With Acquired Haemophilia A: An Interim Safety Analysis of a Large‐Scale Post‑Marketing Surveillance Study
DOI: https://doi.org/10.1111/hae.70301
[2026] Impact of nasogastric administration using the simple suspension method on serum tirabrutinib levels: A case report
DOI: https://doi.org/10.1093/ajhp/zxag190
[2026] Daratumumab-based therapy in systemic AL amyloidosis including advanced cardiac involvement: a single center study
DOI: https://doi.org/10.1007/s12185-026-04225-y
[2026] Prognostic significance of inflammatory cytokine polymorphisms in AML: a study of IFNG, TNFA, and IL1B polymorphisms
DOI: https://doi.org/10.1186/s12865-026-00837-5
[2026] 科学的根拠に基づいた血小板製剤の使用ガイドライン：2025年改訂版
[2026] GUIDELINE FOR THE USE OF PLATELET TRANSFUSION CONCENTRATES BASED ON SCIENTIFIC EVIDENCE: UPDATE 2025
DOI: https://doi.org/10.3925/jjtc.72.17
[2025] Effect of plasma exchange on tirabrutinib plasma concentration in a patient with lymphoplasmacytic lymphoma: A case report
DOI: https://doi.org/10.1007/s00280-025-04812-6
[2025] VIII. Diagnosis and Current Treatment of Acquired Hemophilia A
DOI: https://doi.org/10.2169/naika.114.1262
[2025] Prognostic relevance of early clinical and laboratory findings in immune-mediated thrombotic thrombocytopenic purpura
DOI: https://doi.org/10.1016/j.rpth.2025.102974
[2025] Clinical issue of Differential Diagnosis of Imported Mycosis: A Case Report of a Bolivian Man with Disseminated Histoplasmosis which Mimicked Miliary Tuberculosis
DOI: https://doi.org/10.11150/kansenshogakuzasshi.e24020

続きを表示（残り 41 件）

[2025] Therapeutic switch from plasma to recombinant ADAMTS13 for patients with congenital TTP from Japanese real-world data
DOI: https://doi.org/10.1182/blood.2024027516
[2025] Role of Rac1 in p53-Related Proliferation and Drug Sensitivity in Multiple Myeloma
DOI: https://doi.org/10.3390/cancers17030461
[2025] Diastolic Mitral Regurgitation Caused by Acute Myocardial Infarction Complicated With Severe Heart Failure
DOI: https://doi.org/10.7326/aimcc.2024.0901
[2025] A Case of Acquired Factor V Deficiency in a Hemodialysis Patient: A Case Report With Literature Review
DOI: https://doi.org/10.1002/iju5.70129
[2025] Use of emicizumab in patients with acquired hemophilia A: An interim safety analysis of a large-scale post‑marketing surveillance study
DOI: https://doi.org/10.1182/blood-2025-4854
[2025] Clinical Significance of Lipoprotein Lipase (LPL) in People Living with HIV: A Comprehensive Assessment Including Lipidemia, Body Composition, Insulin Secretion, and Insulin Resistance
DOI: https://doi.org/10.3390/nu17203207
[2025] Serum belumosudil concentrations in a patient receiving a combination of 3 gastric acid–suppressing agents: A case report
DOI: https://doi.org/10.1093/ajhp/zxaf270
[2025] Impact of inflammatory cytokine polymorphisms on the progression of myelodysplastic syndromes
DOI: https://doi.org/10.1007/s00277-025-06614-5
[2024] Real‐World Data on Patients With Acquired Haemophilia A in Japan Undergoing Rehabilitation or With Low Activities of Daily Living Scores: The ORIHIME II Study
DOI: https://doi.org/10.1111/hae.15132
[2024] Role of Ras-Related C3 Botulinus Toxin Substrate 1 in p53-Related Proliferation and Drug Sensitivity in Multiple Myeloma
DOI: https://doi.org/10.1182/blood-2024-204520
[2024] Immediate Therapeutic Intervention for Acute Mortality in Immune-Mediated Thrombotic Thrombocytopenic Purpura with Positive Chest Findings at Initial Presentation
DOI: https://doi.org/10.1182/blood-2024-202956
[2024] Efficacy and safety of recombinant porcine factor VIII in Japanese patients with acquired hemophilia A
DOI: https://doi.org/10.1007/s12185-024-03823-y
[2024] Final Analysis Results from the AGEHA Study: Emicizumab Prophylaxis for Acquired Hemophilia A with or without Immunosuppressive Therapy
DOI: https://doi.org/10.1055/a-2384-3585
[2024] Retrospectively diagnosed autoimmune VWF deficiency in a patient with repeated hemorrhagic events after two common colds
DOI: https://doi.org/10.1007/s12185-024-03782-4
[2024] Persistent ADAMTS13 inhibitor delays recovery of ADAMTS13 activity in caplacizumab-treated Japanese patients with iTTP
DOI: https://doi.org/10.1182/bloodadvances.2023012451
[2024] [Perioperative management for fracture in a child with homozygous congenital protein C deficiency].
DOI: https://doi.org/10.11406/rinketsu.65.164
[2024] [Rehabilitation and outcomes in acquired hemophilia A: a single-center clinical study].
DOI: https://doi.org/10.11406/rinketsu.65.1270
[2023] PB1233 A Single-Center Study of Reduced-Dose Corticosteroids Therapy for Patients with Acquired Hemophilia A
DOI: https://doi.org/10.1016/j.rpth.2023.101047
[2023] PB0328 Outcomes of Immune-Mediated Thrombotic Thrombocytopenic Purpura at a Single Center in Japan
DOI: https://doi.org/10.1016/j.rpth.2023.101458
[2023] PB0211 The Utilities of Multiple Genetic Analyses for Rare Coagulation Deficiencies and Rare Bleeding Disorders
DOI: https://doi.org/10.1016/j.rpth.2023.101283
[2023] Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) in Japan 2023
DOI: https://doi.org/10.1007/s12185-023-03657-0
[2023] [Diagnosis and treatment of autoimmune acquired coagulation factor deficiency].
DOI: https://doi.org/10.11406/rinketsu.64.1116
[2023] Laparoscopic hepatectomy for hepatocellular carcinoma in patients with hemophilia A and B: a report of two cases
DOI: https://doi.org/10.1007/s12328-023-01854-2
[2023] HTRS2023.P2.11 Personalized prophylaxis with simoctocog alfa in adult Japanese previously treated patients with severe hemophilia A
DOI: https://doi.org/10.1016/j.rpth.2023.100234
[2023] A prospective, multicenter, open-label phase III study of emicizumab prophylaxis in patients with acquired hemophilia A
DOI: https://doi.org/10.1016/j.jtha.2022.10.004
[2023] Chronic left ventricular apical thrombosis complicating isolated left ventricular noncompaction in a patient with human immunodeficiency virus infection
DOI: https://doi.org/10.1007/s10396-023-01283-1
[2023] [Acquired hemophilia A that developed after BNT162b2 mRNA COVID-19 vaccination and worsened following re-vaccination].
DOI: https://doi.org/10.11406/rinketsu.64.60
[2023] Total elbow arthroplasty for hemophilic osteoproliferative elbow arthritis with severe flexion contracture: A case report
DOI: https://doi.org/10.1177/2050313x231216597
[2023] [Coagulative complete remission following early gastric cancer resection in a patient with steroid-resistant acquired hemophilia A and nephrotic syndrome].
DOI: https://doi.org/10.11406/rinketsu.64.203
[2022] [Spontaneous disappearance of the inhibitor during emicizumab therapy in a patient with mild hemophilia A].
DOI: https://doi.org/10.11406/rinketsu.63.1392
[2022] Identification of non‐neutralizing anti‐factor X autoantibodies in three Japanese cases of autoimmune acquired factor X deficiency
DOI: https://doi.org/10.1111/hae.14711
[2022] The efficacy and safety of caplacizumab in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura: an open-label phase 2/3 study
DOI: https://doi.org/10.1007/s12185-022-03495-6
[2022] Efficacy and Safety of Personalized Prophylaxis with Simoctocog Alfa in Adult Japanese Previously Treated Patients with Severe Hemophilia a
DOI: https://doi.org/10.1182/blood-2022-167449
[2022] ORIHIME II Study: Background, Treatment Status, and Outcomes of Patients with Acquired Hemophilia A with Low Activities of Daily Living Scores or Undergoing Rehabilitation - a Japanese Health Claims Database Analysis
DOI: https://doi.org/10.1182/blood-2022-157170
[2022] ORIHIME study: real-world treatment patterns and clinical outcomes of 338 patients with acquired hemophilia A from a Japanese administrative database
DOI: https://doi.org/10.1007/s12185-022-03467-w
[2022] Laparoscopic hepatectomy for hepatocellular carcinoma in a patient with congenital factor V deficiency: a case report
DOI: https://doi.org/10.1186/s40792-022-01559-7
[2022] Systemic Lupus Erythematosus Presenting With Thrombotic Thrombocytopenic Purpura at Onset: A Case Report
DOI: https://doi.org/10.3389/fped.2022.931669
[2022] Retrospective examination of coagulation parameters in 33 patients with autoimmune coagulation factor deficiencies in Japan: A single-center analysis
DOI: https://doi.org/10.1016/j.thromres.2022.03.006
[2022] [Refractory thrombotic thrombocytopenic purpura complicated with multiple cerebral infarction].
DOI: https://doi.org/10.11406/rinketsu.63.55
[2022] Antibody pharmaceuticals for thrombo-hemostatic disease
DOI: https://doi.org/10.2491/jjsth.33.433
[2021] Orihime Study: Real World Treatment Patterns and Clinical Outcomes of 338 Patients with Acquired Hemophilia a from a Japanese Health Claims Database
DOI: https://doi.org/10.1182/blood-2021-146418

科研費（0 件）

まだデータがありません（KAKEN 取り込み後に表示）。

所属学会・役職（0 件）

まだデータがありません（学会データ連携後に表示）。

AI 要約（直近 5 年の研究成果）

外部リンク

関連研究室(8 件)

研究成果（51 件）

科研費（0 件）

所属学会・役職（0 件）